Bank Julius Baer & Co
ARKG icon

Bank Julius Baer & Co’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bank Julius Baer & Co’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-220
Closed -$7.22K – 530
2023
Q4 		$7.22K Sell
220
-3
-1% -$82 ﹤0.01% 529
2023
Q3 		$6K Buy
223
+7
+3% +$229 ﹤0.01% 512
2023
Q2 		$7K Sell
216
-4
-2% -$126 ﹤0.01% 548
2023
Q1 		$7K Hold
220
– – ﹤0.01% 574
2022
Q4 		$6K Buy
220
+4
+2% +$127 ﹤0.01% 559
2022
Q3 		$7K Sell
216
-4
-2% -$147 ﹤0.01% 553
2022
Q2 		$7K Buy
+220
New +$7.69K ﹤0.01% 588
2022
Q1 		– Sell
-440
Closed -$27K – 595
2021
Q4 		$27K Sell
440
-4,850
-92% -$335K ﹤0.01% 715
2021
Q3 		$395K Sell
5,290
-451
-8% -$37.8K ﹤0.01% 462
2021
Q2 		$531K Buy
5,741
+451
+9% +$38.3K ﹤0.01% 445
2021
Q1 		$469K Sell
5,290
-6,473
-55% -$642K ﹤0.01% 458
2020
Q4 		$1.1M Buy
+11,763
New +$937K 0.01% 337

Other funds holding ARKG

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Bank Julius Baer & Co's ARKG Position: Q1 2024 in Review

Bank Julius Baer & Co sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2024, closing a stake of 220 shares — an estimated $7.22K sold.

Bank Julius Baer & Co first reported a position in ARKG in Q4 2020 and held it in 12 quarters. The position peaked at $1.1M in Q4 2020. 284 funds tracked by Wall St. Rank hold ARKG as of Q1 2024.

  • Bank Julius Baer & Co reported no remaining ARK Genomic Revolution ETF position as of Q1 2024 after selling out during the quarter.
  • Bank Julius Baer & Co sold 220 ARK Genomic Revolution ETF shares in Q1 2024, an estimated $7.22K.
  • Bank Julius Baer & Co first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 12 quarters.
  • Bank Julius Baer & Co's ARK Genomic Revolution ETF position peaked at $1.1M in Q4 2020.
  • 284 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2024.

Based on Bank Julius Baer & Co's 13F filing for Q1 2024, filed 14 May 2024.